Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anu Jacob

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
Frontiers in Neurology|July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence WorldwideJyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Multiple Sclerosis and Related Disorders|February 21, 2014
Treatment of Neuromyelitis Optica: Review and RecommendationsDorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.
Neurology|October 3, 2022
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With ImagingRosa Cortese, Ferran Prados Carrasco, Carmen Tur, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
CNS Drugs|January 27, 2026
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS GuidelinesBassem Yamout, Riadh Gouider, Raed Al-Roughani, et al.
Neurology|September 28, 2018
Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSDEslam Shosha, Divyanshu Dubey, Jacqueline Palace, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Journal of Neurology|November 5, 2015
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Brian Weinshenker, Gulsen Akman-Demir, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
Frontiers in Neurology|July 17, 2020
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence WorldwideJyh Yung Hor, Nasrin Asgari, Ichiro Nakashima, et al.
Multiple Sclerosis and Related Disorders|February 21, 2014
Treatment of Neuromyelitis Optica: Review and RecommendationsDorlan J Kimbrough, Kazuo Fujihara, Anu Jacob, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 7, 2017
Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter studyRiley Bove, Liene Elsone, Enrique Alvarez, et al.
Neurology|October 3, 2022
Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With ImagingRosa Cortese, Ferran Prados Carrasco, Carmen Tur, et al.
Neurology|June 21, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disordersDean M Wingerchuk, Brenda Banwell, Jeffrey L Bennett, et al.
CNS Drugs|January 27, 2026
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS GuidelinesBassem Yamout, Riadh Gouider, Raed Al-Roughani, et al.
Neurology|September 28, 2018
Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSDEslam Shosha, Divyanshu Dubey, Jacqueline Palace, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2022
Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disordersValentina Damato, Jakob Theorell, Adam Al-Diwani, et al.
JAMA Network Open|January 10, 2022
Factors Associated With Relapse and Treatment of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease in the United KingdomChanjira Satukijchai, Romina Mariano, Silvia Messina, et al.
Journal of Neurology|November 5, 2015
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromesMaciej Juryńczyk, Brian Weinshenker, Gulsen Akman-Demir, et al.
Pageof 15